Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia (CAP5)
Shortened Antibiotic Treatment in Community-Acquired Pneumonia: A Nationwide Danish Randomized Controlled Trial
Sponsor: Thomas Benfield
A PHASE4 clinical study on Community-acquired Pneumonia, this trial is completed. The trial is conducted by Thomas Benfield and has accumulated 11 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
May 2025 — Sep 2025 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Oct 2024 — May 2025 [monthly]
Recruiting PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 6 earlier versions
-
Apr 2023 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Nov 2019 — Oct 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Thomas Benfield
For direct contact, visit the study record on ClinicalTrials.gov .